Source: PharmaTimes

Angelini: Approval provided for Angelini's cenobamate

Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Pierluigi Antonelli's photo - CEO of Angelini

CEO

Pierluigi Antonelli

CEO Approval Rating

50/100

Read more